Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
50,232,186
-
Total 13F shares
-
13,905,857
-
Share change
-
+696,980
-
Total reported value
-
$397,892,000
-
Price per share
-
$28.62
-
Number of holders
-
67
-
Value change
-
+$23,848,401
-
Number of buys
-
37
-
Number of sells
-
21
Institutional Holders of KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) as of Q1 2019
As of 31 Mar 2019 KalVista Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (KALV) had 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,905,857 shares of stock of the company.
Largest 10 holders included SV Health Investors, LLC, RA CAPITAL MANAGEMENT, LLC, Vivo Capital, LLC, Polar Capital LLP, VHCP Management III, LLC, EVENTIDE ASSET MANAGEMENT, LLC, FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and VHCP Management II, LLC.
This table shows 67 institutional shareholders of the security as of 31 Mar 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.